Literature DB >> 17659037

Foam sclerotherapy--a possible option in therapy of varicose veins.

Michael Kendler1, Tino Wetzig, Jan C Simon.   

Abstract

The therapy of varicose veins is multimodal and depends on the individual clinical findings. In addition to compression therapy, invasive approaches for elimination of reflux for the treatment of varicose veins are available, such as surgical and interventional methods and sclerotherapy. The administration of a sclerosing agent into a varicose vein results in an occlusion of the treated vein. Recently the use of foam sclerotherapy had a renaissance. Several studies have documented the efficacy of foam sclerotherapy in selected patients. The possibility of treating patients in an outpatient setting, with low costs and rapidly, makes foam sclerotherapy very attractive compared to invasive and minimally invasive methods. However long-term follow-ups in properly controlled randomized trials are needed before foam sclerotherapy can be recommended as a routine procedure. This paper introduces the method and the treatment possibilities with foam sclerotherapy in chronic venous insufficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659037     DOI: 10.1111/j.1610-0387.2007.06310.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  3 in total

1.  Comparison of high ligation and stripping of the great saphenous vein combined with foam sclerotherapy versus conventional surgery for the treatment of superficial venous varicosities of the lower extremity.

Authors:  Zi-Yuan Zhao; Xiu-Jun Zhang; Jun-Hai Li; Mei Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.

Authors:  Chihiro Itou; Jun Koizumi; Takeshi Hashimoto; Kazunori Myojin; Tatehiro Kagawa; Tetsuya Mine; Yutaka Imai
Journal:  Cardiovasc Intervent Radiol       Date:  2013-10-30       Impact factor: 2.740

3.  A retrospective cohort study comparing two treatments for active venous leg ulcers.

Authors:  Xiaochun Liu; Guofu Zheng; Bo Ye; Weiqing Chen; Hailiang Xie; Teng Zhang; Jing Lin
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.